Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Grimley, Michael S  [Clear All Filters]
Journal Article
Montiel-Esparza R, Michalak SM, Le AHuy Dinh, Or C, Nguyen QDong, Khoury R, Grimley MS, Bertaina A, Klinger E, Shah AJ, et al. Viral-specific T cells for Cytomegalovirus retinitis following hematopoietic stem cell transplantation: A success story. Pediatr Blood Cancer. 2023:e30429.
Khoury R, Grimley MS, Nelson AS, Leemhuis T, Cancelas JA, Cook E, Wang YZ, Heyenbruch D, Bollard CM, Keller MD, et al. Third-party virus specific T cells for the treatment of double stranded DNA viral reactivation and PTLD after solid organ transplant. Am J Transplant. 2024.
Galletta TJ, Lane A, Lutzko C, Leemhuis T, Cancelas JA, Khoury R, Wang YZM, Hanley PJ, Keller MD, Bollard CM, et al. Third party and patient-specific donor-derived virus-specific T cells demonstrate similar efficacy and safety for management of viral infections after hematopoietic stem cell transplant in children and young adults. Transplant Cell Ther. 2023.
Teusink-Cross A, Davies SM, Danziger-Isakov L, El-Bietar J, Grimley MS. Restrictive palivizumab use does not lead to increased morbidity and mortality in pediatric hematopoietic stem cell transplant patients. Biol Blood Marrow Transplant. 2016.
Bender JD, Del Toro HOquendo-, Benoit J, Howell JC, Badia P, Davies SM, Grimley MS, Jodele S, Phillips C, Burns K, et al. Reduced Intensity Conditioning Mitigates Risk for Primary Ovarian Insufficiency but Does Not Decrease Risk for Infertility in Pediatric and Young Adult Survivors of Hematopoietic Stem Cell Transplant: Gonadal Toxicity and Fertility Following Pediatric HSC. Transplant Cell Ther. 2022.
Khandelwal P, Emoto C, Fukuda T, Vinks AA, Neumeier L, Dandoy CE, El-Bietar J, Chandra S, Davies SM, Bleesing JJ, et al. A Prospective Study of Alemtuzumab as a Second Line Agent for Steroid Refractory Acute Graft Versus Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplant. Biol Blood Marrow Transplant. 2016.
Wang YZM, Howell JC, Grimley MS, Lane A, Davies SM, Myers KC. Incidence of thyroid dysfunction in children after HSCT with reduced intensity conditioning (RIC) or myeloablative conditioning (MAC). Pediatr Transplant. 2021:e13983.